ArticlePulmonary circulation

Targeted therapy with phosphodiesterase 5 inhibitors in patients with pulmonary hypertension due to heart failure and elevated pulmonary vascular resistance: a systematic review.

Galo M Sanchez Palacios et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.